Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity

被引:6
|
作者
Yang, Hao [1 ]
Wang, Fang-Ting [1 ]
Wu, Min [1 ]
Wang, Wenjie [2 ]
Agama, Keli [2 ]
Pommier, Yves [2 ]
An, Lin -Kun [1 ,3 ]
机构
[1] Sun Yat sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Peoples R China
[2] Natl Canc Inst, Natl Inst Hlth, Ctr Canc Res, Dev Therapeut Branch, Bethesda, MD 20892 USA
[3] Guangdong Prov Key Lab New Drug Design & Evaluat, Guangzhou 510006, Peoples R China
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
Tyrosyl-DNA phosphodiesterase; Topoisomerase; DNA repair; Anticancer; Benzophenanthridine; TOPOISOMERASE-I INHIBITORS; STRAND BREAK REPAIR; BIOLOGICAL EVALUATION; COVALENT COMPLEXES; SUBSTRATE-BINDING; HUMAN-CELLS; TDP1; DAMAGE; IDENTIFICATION; DEFICIENCY;
D O I
10.1016/j.bioorg.2022.105789
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
& nbsp;Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an enzyme that repairs DNA lesions caused by the trapping of DNA topoisomerase IB (TOP1)-DNA break-associated crosslinks. TDP1 inhibitors have synergistic effect with TOP1 inhibitors in cancer cells and can overcome cancer cell resistance to TOP1 inhibitors. Here, we report the syn-thesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as selective TDP1 inhibitors and show that six compounds 14, 16, 18, 20, 25 and 27 exhibit high TDP1 inhibition potency. The most potent TDP1 inhibitor 14 (IC50 = 1.7 +/- 0.24 mu M) induces cellular TDP1cc formation and shows synergistic effect with topotecan in four human cancer cell lines MCF-7, A549, H460 and HepG2.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Structure Modeling of Human Tyrosyl-DNA Phosphodiesterase 1 and Screening for Its Inhibitors
    Gushchina, I. V.
    Nilov, D. K.
    Zakharenko, A. L.
    Lavrik, O. I.
    Svedas, V. K.
    ACTA NATURAE, 2017, 9 (02): : 59 - 66
  • [22] Usnic Acid Conjugates with Monoterpenoids as Potent Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
    Luzina, Olga
    Filimonov, Alexander
    Zakharenko, Alexandra
    Chepanova, Arina
    Zakharova, Olga
    Ilina, Ekaterina
    Dyrkheeva, Nadezhda
    Likhatskaya, Galina
    Salakhutdinov, Nariman
    Lavrik, Olga
    JOURNAL OF NATURAL PRODUCTS, 2020, 83 (08): : 2320 - 2329
  • [23] Enhancement of the Clastogenic Effects of Topotecan In Vivo by Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
    Zhanataev, A. K.
    Kulakova, A. V.
    Luzina, O. A.
    Khomenko, T. M.
    Volcho, K. P.
    Salakhutdinov, N. F.
    Durnev, A. D.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 177 (01) : 30 - 34
  • [24] Robustadial A and B from Eucalyptus globulus Labill. and their anticancer activity as selective tyrosyl-DNA phosphodiesterase 2 inhibitors
    Zhang, Yu
    He, Xiao-Zhi
    Yang, Hao
    Liu, Hai-Yang
    An, Lin-Kun
    PHYTOTHERAPY RESEARCH, 2021, 35 (09) : 5282 - 5289
  • [25] Selection of bifunctional tyrosyl-DNA phosphodiesterase 1 inhibitors through molecular modeling
    Gushchina, I.
    Svedas, V.
    Nilov, D.
    FEBS OPEN BIO, 2018, 8 : 455 - 455
  • [26] Secondary metabolites from Isodon ternifolius (D. Don) Kudo and their anticancer activity as DNA topoisomerase IB and Tyrosyl-DNA phosphodiesterase 1 inhibitors
    Zhang, Hong-Li
    Zhang, Yu
    Yan, Xue-Long
    Xiao, Long-Gao
    Hu, De-Xuan
    Yu, Qian
    An, Lin-Kun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (11)
  • [27] Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2)
    Yu, Le-Mao
    Hu, Zhu
    Chen, Yu
    Ravji, Azhar
    Lopez, Sophia
    Plescia, Caroline B.
    Yu, Qian
    Yang, Hui
    Abdelmalak, Monica
    Saha, Sourav
    Agama, Keli
    Kiselev, Evgeny
    Marchand, Christophe
    Pommier, Yves
    An, Lin-Kun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 151 : 777 - 796
  • [28] Flexible docking of the inhibitors into Tyrosyl-DNA Phosphodiesterase (Tdp1) active sites
    Weidlich, Iwona
    Nicklaus, Marc C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [29] Human Tyrosyl-DNA Phosphodiesterase 1 Possesses Transphosphooligonucleotidation Activity With Primary Alcohols
    Dyrkheeva, Nadezhda
    Anarbaev, Rashid
    Lebedeva, Natalia
    Kuprushkin, Maxim
    Kuznetsova, Alexandra
    Kuznetsov, Nikita
    Rechkunova, Nadejda
    Lavrik, Olga
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [30] Newly developed piperidinyl sulfamides as tyrosyl-DNA phosphodiesterase 1 (Tdp1) inhibitors
    Malhotra, Sanjay V.
    Pommier, Yves
    Jun, Jung Ho
    Dexheimer, Thomas S.
    Gupta, Shalu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238